News and Press Releases
ANP Technologies, in Partnership with Fulgent Pharma, Teams with Moffitt Cancer Center to Develop a New Class of Leukemia Therapies
Add some more info about this item...
ANP Technologies Inc. (ANP) and Fulgent Pharma LLC through their partner Moffitt Cancer Center have successfully licensed the rights to develop a novel targeted therapy in the area of leukemia to Celgene (CELG), now Bristol Myers Squibb (BMY), a landmark deal that leverages ANP’s nanotherapeutic platform technology. The partners will work together to develop a new cancer therapy for Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). The potential new therapy will target a novel pathway receptor.
Add some more info about this item...
Add some more info about this item...
Add some more info about this item...
The U.S. Food and Drug Administration (FDA) has granted approval for ANP Technologies, Inc. and its partner to begin Phase I clinical trials with its first drug – nanoencapsulated paclitaxel.
Add some more info about this item...
What's this item about? What makes it interesting? Write a catchy description to grab your audience's attention...
ANP Technologies® Inc receives Innovators Award from Delaware Bioscience Association
Add some info about this item
Tell people more about this item. What's it about and what makes it interesting? Give people the info they need to go ahead and take the action you want.
To make this item your own, click here > Add & Manage Items.
Our Technologies
Defense
Our NIDS® rapid and handheld assays are widely used by the U.S. military and first responders to detect biological and chemical agent threats.
Therapeutics
Using its library of patented polymers, ANP has successfully nanoencapsulated both small and large molecule drugs to improve pharmacokinetics, reduce toxicity, and enhance therapeutic efficacy, & stability. ANP has multiple drugs at the IND stage or beyond!
Immunogenicity
ANP has the best immunogenicity testing products on the market including the renowned ANPEG-1 IgM antibody, comprehensive PEG ELISA Kits, and customizable kits for any application.
Life Science
We offer a premier portfolio of life science products including ANPEG Antibody, Streptavidin & Neutravidin ELISA Plates, Protein Labeling & Extraction Kits, Reagents, & more.
